论文部分内容阅读
根据1991年全国药品质量抽验计划,中国药品生物制品检定所在全国范围内抽取了注射用细胞色素C、贝诺酯(片)、吲哚美辛(胶囊)、咖啡因、多酶片、安乃近片、鲎试剂等9个品种、48个生产单位、计132批次,按照中国药典、药品标准进行全检,其中24批次不合格。 不合格的药品有(括弧内为批号):(1)吲哚美辛胶囊:天津市中央制药二厂(9101040);(2)多酶片:常州生化药厂(910528—2),重庆市合川生化药厂(910413、910414、910415),
According to the 1991 National Quality Inspection Plan for Drugs, China National Institute for the Control of Pharmaceutical and Biological Products has extracted a series of drugs such as Cytochrome C, Benobuterol (tablets), Indomethacin (Capsule), Caffeine, Nearly films, 鲎 reagents and other 9 varieties, 48 production units, accounting for 132 batches, in accordance with the Chinese Pharmacopoeia, pharmaceutical standards for the whole seizure, of which 24 batches failed. (1) indomethacin capsules: Tianjin Central Pharmaceutical Factory (9101040); (2) multi-enzyme tablets: Changzhou Biochemical Pharmaceutical Factory (910528-2), Chongqing Municipality Hechuan Biochemical Pharmaceutical Factory (910,413,910,414,910,415),